Johnson & Johnson (JNJ) on Sunday reported positive 30-day results from a clinical trial of its experimental Shockwave Javelin catheter, designed to treat severely narrowed coronary arteries that are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results